Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Comment by ValueRideron May 19, 2024 10:26am
46 Views
Post# 36047911

RE:RE:SEC Sub-pena

RE:RE:SEC Sub-pena

KarlGibbons wrote: I guess no one read the financial statement notes under "Contingencies" where there is mention of the SEC probe in April.  There will now be more legal fees!  The $1 million they spent in Q2 was very large and indicates this DOJ CID inquiry is probably a big deal.  Investors were likely very spooked by that and the SEC probe.  I don't think folks liked the changing organic growth definition (Year over Year vs sequential) and the FCF definition, which excludes taxes, working capital investments and the full transfer from inventory figures...
The buyback doesn't do much here as most of the volume is on the Nasdaq and they are only doing an NCIB in Canada with limited buying capacity.  Given the tight liquidity situation and the potential large settlement brewing with the DOJ, one wonders if their lenders are going to strong arm them into a forced equity raise soon.

Wow, how much time did you waste trying to come up with those nonsensical assumptions? 


ignored! Buh-bye!

<< Previous
Bullboard Posts
Next >>